Data search
Results for MligTC455_25197
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_25197 | 36 | 0.74 | Mlig455_059562 | Neo: - Age: - |
KY | Mlig455_059562 {REF} {Length: 5559} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=77.0, Expect=2e-13]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=79.0, Expect=2e-14]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=78.6, Expect=3e-14]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=68.2, Expect=3e-11]} {Smed: dd_Smed_v6_1109_0_1, dd_Smed_v6_1109_0_1, [Score=100, Expect=5e-21]} {RNA1509_6021} {RNA1310_875.1} {RNA815_349} |
Cumulative graph for MligTC455_25197
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.458 | 1.244 | 0.99979 | 1.00000 | |
| RegionR2 | 1.884 | 1.244 | 0.23206 | 0.60466 | |
| RegionR3 | 1.039 | 1.244 | 0.32133 | 0.85899 | |
| RegionR4 | 0.606 | 1.244 | 0.55836 | 0.87837 | |
| RegionR5 | -1.157 | 1.244 | 0.87612 | 1.00000 | |
| RegionR6 | -2.996 | 1.244 | 0.99981 | 1.00000 | |
| RegionR7 | 2.763 | 1.244 | 0.14049 | 0.70111 | |
| RegionR8 | -1.68 | 1.244 | 0.99976 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 0.285 | 1.244 | 0.99993 | 1.00000 | |
| RegenerationR2 | 2.273 | 1.244 | 0.02566 | 0.26436 | |
| RegenerationR3 | 2.42 | 1.244 | 0.07542 | 0.45719 | |
| RegenerationR4 | 1.567 | 1.244 | 0.29381 | 0.73725 | |
| RegenerationR5 | 2.702 | 1.244 | 0.03155 | 0.29620 | |
| RegenerationR6 | 3.865 | 1.244 | 0.06006 | 0.30828 | |
| RegenerationBL | -0.594 | 1.244 | 0.99975 | 1.00000 | |
| RegenerationTP | 3.67 | 1.244 | 0.07953 | 0.44971 |
Genes with expression patterns similar to MligTC455_25197
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_25197 | 36 | 0.74 | Mlig455_059562 | Neo: - Age: - |
KY | 4 | 1.000 | - | - | 1.000 | 1.000 | 1.000 | Mlig455_059562 {REF} {Length: 5559} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=77.0, Expect=2e-13]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=79.0, Expect=2e-14]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=78.6, Expect=3e-14]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=68.2, Expect=3e-11]} {Smed: dd_Smed_v6_1109_0_1, dd_Smed_v6_1109_0_1, [Score=100, Expect=5e-21]} {RNA1509_6021} {RNA1310_875.1} {RNA815_349} |
| 2. | MligTC455_15134 | 15 | 0.31 | Mlig455_000804 | Neo: - Age: - |
CNGA3 | 1.865 | 0.882 | - | - | - | 0.983 | - | Mlig455_000804 {REF} {Length: 2294} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.8]; Ion transport protein [PF00520.33, score=39.4]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=351, Expect=2e-113]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=344, Expect=2e-110]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=340, Expect=2e-109]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=352, Expect=9e-115]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=342, Expect=7e-110]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=338, Expect=9e-109]} {Dmel: FBgn0259145, CG42260, [Score=463, Expect=1e-153]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=281, Expect=1e-86]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=343, Expect=2e-111]} {RNA1310_120793} {RNA815_25814} |
| 3. | MligTC455_18161 | 771 | 16.05 | Mlig455_031626, Mlig455_048205 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.318/0.00160 |
1.798 | 0.844 | - | - | - | 0.954 | - | Mlig455_031626 {REF} {Length: 835} {TRANSSPLICED} {RNA1509_48514} {RNA1310_56583, RNA1509_48514} {RNA1509_48514, RNA815_34758} Mlig455_048205 {REF} {Length: 651} {RNA1509_48514} {RNA1310_56583} {RNA815_34758} |
|
| 4. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 1.793 | 0.827 | - | - | - | 0.966 | - | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
| 5. | MligTC455_05694 | 26 | 0.54 | Mlig455_051272 | Neo: - Age: - |
1.791 | - | - | - | 0.968 | 0.823 | - | Mlig455_051272 {REF} {Length: 3382} {RNA1509_16377} {RNA1310_51000} {RNA815_34468.1} | |
| 6. | MligTC455_52935 | 29 | 0.61 | Mlig455_014479 | Neo: - Age: - |
PROX1 | 1.774 | 0.798 | - | - | - | 0.976 | - | Mlig455_014479 {REF} {Length: 1320} {Pfam: Homeo-prospero domain [PF05044.14, score=192.8]} {Human: ENSG00000117707, PROX1, prospero homeobox 1, [Score=163, Expect=5e-44]; ENSG00000119608, PROX2, prospero homeobox 2, [Score=159, Expect=4e-43]} {Mouse: ENSMUSG00000010175, Prox1, prospero homeobox 1, [Score=163, Expect=4e-44]; ENSMUSG00000042320, Prox2, prospero homeobox 2, [Score=162, Expect=2e-44]} {Dmel: FBgn0004595, pros, prospero, [Score=182, Expect=1e-50]} {Celegans: WBGene00000448, pros-1, Homeobox protein prospero homolog 1, [Score=178, Expect=1e-50]} {Smed: dd_Smed_v6_48508_0_1, dd_Smed_v6_48508_0_1, [Score=165, Expect=9e-50]} {RNA1310_102283} |
| 7. | MligTC455_22837 | 484 | 10.08 | Mlig455_005509, Mlig455_006648, Mlig455_006694, Mlig455_010631, Mlig455_023501, Mlig455_030951, Mlig455_032677 | Neo: - Age: Up-Down-Up |
1.756 | - | - | - | - | 0.961 | 0.795 | Mlig455_005509 {REF} {Length: 1003} {TRANSSPLICED} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_006648 {REF} {Length: 2757} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_006694 {REF} {Length: 1368} {RNA1310_105426} {RNA815_46313} Mlig455_010631 {REF} {Length: 1245} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_023501 {REF} {Length: 1139} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_030951 {REF} {Length: 1003} {TRANSSPLICED} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_032677 {REF} {Length: 1003} {TRANSSPLICED} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} |
|
| 8. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
1.752 | 0.798 | - | - | - | 0.954 | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
| 9. | MligTC455_52223 | 30 | 0.62 | Mlig455_029799 | Neo: - Age: - |
GLRA2 | 1.741 | - | - | - | 0.750 | 0.991 | - | Mlig455_029799 {REF} {Length: 3197} {tRNA: Val(CAC),pseudo, score=27.6} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=122.6]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=350, Expect=1e-116]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=345, Expect=4e-115]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=338, Expect=3e-112]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=345, Expect=3e-115]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=342, Expect=2e-113]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=337, Expect=9e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=334, Expect=1e-110]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=301, Expect=8e-98]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [RH, Score=274, Expect=3e-88]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=265, Expect=1e-84]} {RNA1509_44790} {RNA1310_18585} {RNA815_38424} |
| 10. | MligTC455_07469 | 44 | 0.92 | Mlig455_053361 | Neo: - Age: Up-Up-Down |
DLX1 | 1.723 | - | - | - | 0.755 | 0.968 | - | Mlig455_053361 {REF} {Length: 1777} {Pfam: Homeodomain [PF00046.31, score=72.7]} {Human: ENSG00000144355, DLX1, distal-less homeobox 1, [RH, Score=142, Expect=3e-39]} {Mouse: ENSMUSG00000041911, Dlx1, distal-less homeobox 1, [RH, Score=142, Expect=2e-39]; ENSMUSG00000029754, Dlx6, distal-less homeobox 6, [RH, Score=137, Expect=3e-37]} {Dmel: FBgn0000157, Dll, Distal-less, [RH, Score=138, Expect=1e-37]} {Celegans: WBGene00000463, ceh-43, Homeobox protein ceh-43, [RH, Score=102, Expect=6e-25]} {Smed: dd_Smed_v6_19040_0_1, dd_Smed_v6_19040_0_1, [RH, Score=159, Expect=7e-44]} {RNA1509_39701} {RNA1310_24974} {RNA815_26393} |
| 11. | MligTC455_11736 | 19 | 0.39 | Mlig455_031660 | Neo: - Age: - |
1.703 | - | - | - | - | 0.744 | 0.959 | Mlig455_031660 {REF} {Length: 680} {RNA1310_76333} {RNA815_54433} | |
| 12. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
1.696 | 0.743 | - | - | - | 0.953 | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
| 13. | MligTC455_10024 | 48 | 0.99 | Mlig455_065062 | Neo: - Age: - |
1.693 | - | - | - | - | 0.959 | 0.734 | Mlig455_065062 {REF} {Length: 3160} {RNA1310_7348} {RNA815_14995} | |
| 14. | MligTC455_49907 | 79 | 1.65 | Mlig455_059454 | Neo: - Age: Up-Down-Down |
0.995 | - | - | - | - | 0.995 | - | Mlig455_059454 {REF} {Length: 2213} {Pfam: Otopetrin [PF03189.15, score=92.9]} {Dmel: FBgn0259994, CG42492, [Score=79.3, Expect=3e-16]} {Celegans: WBGene00018478, otpl-5, OToPetrin-Like, [Score=75.5, Expect=3e-15]} {Smed: dd_Smed_v6_15458_0_1, dd_Smed_v6_15458_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_31431.1} {RNA815_29709} | |
| 15. | MligTC455_51179 | 75 | 1.55 | Mlig455_068660 | Neo: - Age: - |
WEE2 | 0.976 | - | - | - | - | 0.976 | - | Mlig455_068660 {REF} {Length: 3046} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=86.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.7]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.4]} {Human: ENSG00000263042, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]; ENSG00000214102, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]} {Mouse: ENSMUSG00000037159, Wee2, WEE1 homolog 2 (S. pombe), [Score=102, Expect=2e-22]} {Dmel: FBgn0040298, Myt1, [Score=82.0, Expect=6e-16]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_17244_0_1, dd_Smed_v6_17244_0_1, [Score=73.9, Expect=1e-13]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
| 16. | MligTC455_25414 | 32 | 0.66 | Mlig455_000371 | Neo: - |
TRPM3 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_000371 {REF} {Length: 4372} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=75.7]; Ankyrin repeats (many copies) [PF13637.8, score=64.1]; Ankyrin repeat [PF13606.8, score=39.6]; Ankyrin repeats (many copies) [PF13857.8, score=31.8]; Ankyrin repeat [PF00023.32, score=27.0]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=80.1, Expect=2e-14]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=79.3, Expect=3e-14]; ENSMUSG00000027365, Trpm7, transient receptor potential cation channel, subfamily M, member 7, [Score=76.6, Expect=2e-13]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=78.6, Expect=3e-14]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=64.7, Expect=4e-10]} {Smed: dd_Smed_v6_26251_0_1, dd_Smed_v6_26251_0_1, [Score=79.3, Expect=8e-15]} {RNA1509_18305} {RNA1310_1324.1} {RNA815_16630} |
| 17. | MligTC455_53118 | 133 | 2.76 | Mlig455_029477 | Neo: - Age: - |
CHRNA2 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
| 18. | MligTC455_00799 | 5 | 0.1 | Mlig455_009712 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_009712 {REF} {Length: 594} {NoTransDecoderORF} {RNA815_17525} | |
| 19. | MligTC455_48320 | 81 | 1.69 | Mlig455_008829 | Neo: - Age: Down-Down-Up |
TOB1 | 0.973 | - | - | - | - | 0.973 | - | Mlig455_008829 {REF} {Length: 832} {Pfam: BTG family [PF07742.14, score=62.3]} {Human: ENSG00000141232, TOB1, transducer of ERBB2, 1, [Score=64.7, Expect=2e-12]} {Mouse: ENSMUSG00000037573, Tob1, transducer of ErbB-2.1, [Score=63.2, Expect=4e-12]} {Dmel: FBgn0028397, Tob, [Score=68.6, Expect=5e-14]} {Smed: dd_Smed_v6_7444_0_1, dd_Smed_v6_7444_0_1, [Score=75.1, Expect=5e-17]} {RNA1509_42403, RNA1509_59615} {RNA1310_49803, RNA1509_42403, RNA1509_59615} |
| 20. | MligTC455_13734 | 19 | 0.4 | Mlig455_066088 | Neo: - Age: Down-Up-Down |
0.972 | - | - | - | - | 0.972 | - | Mlig455_066088 {REF} {Length: 1207} {RNA1310_47485} {RNA815_44269} | |
| 21. | MligTC455_19097 | 120 | 2.49 | Mlig455_035179 | Neo: - Age: - Region-enriched R2: 5.873/0.00339 |
KCNK3 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_035179 {REF} {Length: 2899} {Pfam: Ion channel [PF07885.18, score=103.1]; Ion transport protein [PF00520.33, score=23.8]} {Human: ENSG00000171303, KCNK3, potassium two pore domain channel subfamily K member 3, [Score=67.0, Expect=5e-11]; ENSG00000169427, KCNK9, potassium two pore domain channel subfamily K member 9, [Score=65.9, Expect=1e-10]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=72.4, Expect=6e-13]} {Dmel: FBgn0033257, sand, sandman, [Score=105, Expect=4e-24]} {Celegans: WBGene00006690, twk-39, TWiK family of potassium channels, [RH, Score=117, Expect=4e-27]} {Smed: dd_Smed_v6_21895_0_1, dd_Smed_v6_21895_0_1, [RH, Score=188, Expect=7e-51]} {RNA1310_31604} {RNA815_54785} |
| 22. | MligTC455_51398 | 351 | 7.32 | Mlig455_000583 | Neo: - Age: - |
KCNT1 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_000583 {REF} {Length: 4688} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=91.5]; Ion channel [PF07885.18, score=43.5]} {Human: ENSG00000107147, KCNT1, potassium sodium-activated channel subfamily T member 1, [RH, Score=1147, Expect=0.0]; ENSG00000162687, KCNT2, potassium sodium-activated channel subfamily T member 2, [RH, Score=1132, Expect=0.0]} {Mouse: ENSMUSG00000052726, Kcnt2, potassium channel, subfamily T, member 2, [RH, Score=1132, Expect=0.0]; ENSMUSG00000058740, Kcnt1, potassium channel, subfamily T, member 1, [RH, Score=1120, Expect=0.0]} {Dmel: FBgn0261698, SLO2, slowpoke 2, [RH, Score=838, Expect=0.0]} {Celegans: WBGene00004831, slo-2, SLO-2 potassium channel; SLOwpoke potassium channel family, [RH, Score=848, Expect=0.0]} {Smed: dd_Smed_v6_9739_0_1, dd_Smed_v6_9739_0_1, [RH, Score=1364, Expect=0.0]} {RNA1509_10851} {RNA1310_11341} {RNA815_3987} |
| 23. | MligTC455_43851 | 79 | 1.64 | Mlig455_031738 | Neo: - Age: - |
PI16 | 0.971 | - | - | - | - | 0.971 | - | Mlig455_031738 {REF} {Length: 2697} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=65.5]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=82.4, Expect=4e-16]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=83.2, Expect=2e-16]} {Dmel: FBgn0038126, CG8483, [Score=48.5, Expect=9e-06]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.0, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=139, Expect=3e-35]} {RNA1509_36211} {RNA1310_15740, RNA1509_36211} {RNA1509_36211, RNA815_1860.1} |
| 24. | MligTC455_47481 | 208 | 4.33 | Mlig455_066050 | Neo: - Age: - Region-enriched R2: 3.601/0.00192 |
0.971 | - | - | - | - | 0.971 | - | Mlig455_066050 {REF} {Length: 1418} {RNA1310_25309} {RNA815_22558.1} | |
| 25. | MligTC455_51177 | 76 | 1.59 | Mlig455_058323 | Neo: - Age: Down-Up-Up |
SAXO1 | 0.971 | - | - | - | - | 0.971 | - | Mlig455_058323 {REF} {Length: 1875} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.1, Expect=1e-05]} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=60.8, Expect=5e-11]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
| 26. | MligTC455_29317 | 89 | 1.85 | Mlig455_062533 | Neo: - Age: logFC(26M/2M)=0.866 |
SLC18A3 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_062533 {REF} {Length: 3319} {Pfam: Major Facilitator Superfamily [PF07690.18, score=140.0]; LacY proton/sugar symporter [PF01306.21, score=22.0]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=457, Expect=1e-155]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=462, Expect=8e-158]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=512, Expect=6e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=474, Expect=6e-163]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=535, Expect=0.0]} {RNA1509_22907} {RNA1310_5498.1, RNA1509_22907} {RNA1509_22907, RNA815_3951} |
| 27. | MligTC455_43950 | 2296 | 47.84 | Mlig455_029261, Mlig455_035647, Mlig455_035748 | Neo: - Age: - Regeneration-downregulated BL: -2.094 Regeneration-depleted BL: -2.094 |
0.97 | - | - | - | - | 0.970 | - | Mlig455_029261 {REF} {Length: 2798} {RNA1509_28538, RNA1509_39513, RNA1509_9241} {RNA1310_10383, RNA1509_28538, RNA1509_39513, RNA1509_9241} {RNA1509_28538, RNA1509_39513, RNA1509_9241, RNA815_3519} Mlig455_035647 {REF} {Length: 2505} {RNA1509_9241} {RNA1310_10383} {RNA815_3519} Mlig455_035748 {REF} {Length: 2496} {RNA1509_9241} {RNA1310_10383} {RNA815_3519} |
|
| 28. | MligTC455_05283 | 200 | 4.17 | Mlig455_034021, Mlig455_060399 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.841 Region-enriched R7: 2.636/0.00077 Regeneration-downregulated BL: -7.376 Regeneration-depleted BL: -7.376 |
0.969 | - | - | - | - | - | 0.969 | Mlig455_034021 {REF} {Length: 1260} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=63.7]} {RNA1310_41325} {RNA815_53338} Mlig455_060399 {REF} {Length: 2102} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=63.8]} {RNA1509_57769} {RNA1310_41325} {RNA815_53338} |
|
| 29. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
| 30. | MligTC455_17468 | 54 | 1.13 | Mlig455_013421 | Neo: - Age: - Region-enriched R2: 9.270/0.00000 |
LUZP4 | 0.969 | - | - | - | - | 0.969 | - | Mlig455_013421 {REF} {Length: 1578} {Human: ENSG00000102021, LUZP4, leucine zipper protein 4, [RH, Score=62.8, Expect=5e-11]} {RNA1310_64423.1} {RNA815_29788} |
| 31. | MligTC455_20769 | 86 | 1.8 | Mlig455_058483 | Neo: - Age: Up-Down-Down |
CALCR | 0.969 | - | - | - | - | 0.969 | - | Mlig455_058483 {REF} {Length: 1844} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=149.2]; Hormone receptor domain [PF02793.24, score=37.6]} {Human: ENSG00000004948, CALCR, calcitonin receptor, [Score=140, Expect=3e-36]} {Mouse: ENSMUSG00000023964, Calcr, calcitonin receptor, [Score=147, Expect=1e-38]} {Dmel: FBgn0260753, Pdfr, Pigment-dispersing factor receptor, [Score=213, Expect=5e-62]} {Celegans: WBGene00015735, pdfr-1, Calcitonin receptor-like protein 1, [Score=178, Expect=4e-50]} {Smed: dd_Smed_v6_22246_0_1, dd_Smed_v6_22246_0_1, [RH, Score=199, Expect=4e-59]} {RNA1310_16931.2} {RNA815_17279} |
| 32. | MligTC455_38813 | 50 | 1.04 | Mlig455_008881 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.104/0.01060 |
THSD7A | 0.968 | - | - | - | - | 0.968 | - | Mlig455_008881 {REF} {Length: 6770} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=138.6]; Thrombospondin type 1 domain [PF19030.2, score=34.2]; Thrombospondin type 1 domain [PF00090.21, score=26.3]} {Human: ENSG00000005108, THSD7A, thrombospondin type 1 domain containing 7A, [Score=298, Expect=5e-81]} {Mouse: ENSMUSG00000032625, Thsd7a, thrombospondin, type I, domain containing 7A, [Score=303, Expect=8e-83]} {Celegans: WBGene00001650, gon-1, A disintegrin and metalloproteinase with thrombospondin motifs gon-1, [Score=54.7, Expect=8e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=50.4, Expect=1e-05]} {RNA1310_90350} |
| 33. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
| 34. | MligTC455_12202 | 65 | 1.36 | Mlig455_049470 | Neo: - Age: - |
0.967 | - | - | - | 0.967 | - | - | Mlig455_049470 {REF} {Length: 998} {NoTransDecoderORF} {RNA1310_32030.1} {RNA815_32240} | |
| 35. | MligTC455_15996 | 396 | 8.26 | Mlig455_064976, Mlig455_066809 | Neo: - Age: - |
ARHGEF17 | 0.967 | - | - | - | - | 0.967 | - | Mlig455_064976 {REF} {Length: 4968} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=136.4]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [Score=233, Expect=6e-61]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [Score=239, Expect=3e-63]} {Dmel: FBgn0262562, CG43102, [RH, Score=520, Expect=4e-156]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [RH, Score=240, Expect=2e-64]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=713, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_14497} Mlig455_066809 {REF} {Length: 5061} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=125.9]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [RH, Score=266, Expect=2e-71]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [RH, Score=264, Expect=1e-70]} {Dmel: FBgn0262562, CG43102, [RH, Score=503, Expect=8e-150]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [Score=224, Expect=3e-59]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_23184} |
| 36. | MligTC455_52746 | 33 | 0.7 | Mlig455_036774 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348} | |
| 37. | MligTC455_11460 | 16 | 0.32 | Mlig455_007663, Mlig455_020976 | Neo: - Age: - |
GABBR2 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_007663 {REF} {Length: 3796} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.8]; Receptor family ligand binding region [PF01094.30, score=95.6]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=192, Expect=5e-51]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=192, Expect=4e-51]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=184, Expect=2e-48]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=135, Expect=1e-35]} {RNA1509_46835} {RNA1310_28203} {RNA815_41974} Mlig455_020976 {REF} {Length: 3353} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.3]; Receptor family ligand binding region [PF01094.30, score=128.3]; Periplasmic binding protein [PF13458.8, score=20.5]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=256, Expect=8e-73]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=250, Expect=7e-71]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=230, Expect=2e-63]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=203, Expect=3e-55]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=133, Expect=7e-35]} {RNA1310_28203} {RNA815_36847} |
| 38. | MligTC455_24907 | 223 | 4.65 | Mlig455_030279, Mlig455_057569 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.855 Region-enriched R3: 3.478/0.00051 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_030279 {REF} {Length: 1440} {RNA1310_18429.2} {RNA815_17761} Mlig455_057569 {REF} {Length: 749} {RNA1310_18429.2} {RNA815_17761} |
|
| 39. | MligTC455_39632 | 71 | 1.48 | Mlig455_039338 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.404/0.02299 |
APBA1 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_039338 {REF} {Length: 5781} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=122.8]; PDZ domain [PF00595.26, score=87.0]; PDZ domain [PF17820.3, score=50.7]} {Human: ENSG00000107282, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=476, Expect=5e-157]; ENSG00000276497, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=474, Expect=2e-161]; ENSG00000276495, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]; ENSG00000034053, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]} {Mouse: ENSMUSG00000030519, Apba2, amyloid beta (A4) precursor protein-binding, family A, member 2, [RH, Score=476, Expect=3e-158]; ENSMUSG00000024897, Apba1, amyloid beta (A4) precursor protein binding, family A, member 1, [RH, Score=475, Expect=2e-156]} {Dmel: FBgn0052677, X11Lbeta, [Score=532, Expect=2e-168]} {Celegans: WBGene00002999, lin-10, [Score=519, Expect=1e-172]} {Smed: dd_Smed_v6_2836_0_2, dd_Smed_v6_2836_0_2, [Score=550, Expect=0.0]} {RNA1509_43941, RNA1509_55204} {RNA1310_18864.1, RNA1509_43941} {RNA1509_43941, RNA815_11653} |
| 40. | MligTC455_52351 | 280 | 5.84 | Mlig455_037161, Mlig455_038476, Mlig455_052313 | Neo: - Age: Down-Up-Up Region-enriched R8: 4.109/0.00021 |
CALM2 | 0.965 | - | - | - | - | - | 0.965 | Mlig455_037161 {REF} {Length: 1076} {Pfam: EF-hand domain pair [PF13499.8, score=39.3]; EF hand [PF00036.34, score=24.4]; EF-hand domain [PF13405.8, score=24.1]; EF-hand domain pair [PF13833.8, score=21.3]; EF-hand domain [PF14658.8, score=21.2]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=93.2, Expect=2e-22]; ENSG00000160014, CALM3, calmodulin 3, [Score=92.4, Expect=2e-22]; ENSG00000198668, CALM1, calmodulin 1, [Score=92.4, Expect=1e-22]; ENSG00000178363, CALML3, calmodulin like 3, [Score=90.1, Expect=1e-21]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=93.2, Expect=2e-22]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=92.4, Expect=1e-22]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=92.4, Expect=1e-22]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=92.4, Expect=1e-22]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=92.0, Expect=1e-22]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=92.0, Expect=9e-23]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=92.0, Expect=7e-23]} {RNA1310_8603.1} {RNA815_31151.1} Mlig455_038476 {REF} {Length: 855} {Pfam: EF-hand domain pair [PF13499.8, score=40.9]; EF hand [PF00036.34, score=26.1]; EF-hand domain [PF13405.8, score=25.6]; EF-hand domain pair [PF13833.8, score=22.7]; EF-hand domain [PF14658.8, score=22.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=92.4, Expect=8e-23]; ENSG00000160014, CALM3, calmodulin 3, [Score=92.0, Expect=5e-23]; ENSG00000198668, CALM1, calmodulin 1, [Score=92.0, Expect=5e-23]; ENSG00000178363, CALML3, calmodulin like 3, [Score=89.0, Expect=7e-22]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=92.4, Expect=8e-23]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=92.0, Expect=4e-23]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=92.0, Expect=4e-23]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=91.3, Expect=6e-23]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=91.3, Expect=5e-23]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=90.9, Expect=4e-23]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=90.9, Expect=3e-23]} {RNA1310_8603.1} {RNA815_31151.1} Mlig455_052313 {REF} {Length: 1073} {Pfam: EF-hand domain pair [PF13499.8, score=33.5]; EF hand [PF00036.34, score=23.1]; EF-hand domain pair [PF13833.8, score=21.8]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=80.9, Expect=5e-18]; ENSG00000198668, CALM1, calmodulin 1, [Score=80.5, Expect=3e-18]; ENSG00000160014, CALM3, calmodulin 3, [Score=80.1, Expect=3e-18]; ENSG00000178363, CALML3, calmodulin like 3, [Score=79.3, Expect=7e-18]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=81.3, Expect=9e-19]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=80.9, Expect=3e-18]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=80.1, Expect=2e-18]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=80.1, Expect=2e-18]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=79.7, Expect=3e-18]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=79.7, Expect=2e-18]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=79.7, Expect=2e-18]} {RNA1310_8603.1} {RNA815_31151.1} |
| 41. | MligTC455_03732 | 6 | 0.12 | Mlig455_030369, Mlig455_030417 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_030369 {REF} {Length: 1440} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=51.6, Expect=3e-07]} {Celegans: WBGene00016149, frpr-3, FMRFamide Peptide Receptor family; VRFamide receptor 1, [Score=53.5, Expect=3e-08]} {Smed: dd_Smed_v6_29019_0_1, dd_Smed_v6_29019_0_1, [Score=116, Expect=2e-30]} Mlig455_030417 {REF} {Length: 2861} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=67.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=32.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.1]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=63.5, Expect=2e-10]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=69.3, Expect=2e-12]} {Smed: dd_Smed_v6_29019_0_1, dd_Smed_v6_29019_0_1, [Score=171, Expect=6e-49]} |
|
| 42. | MligTC455_10031 | 15 | 0.3 | Mlig455_010990 | Neo: - Age: - |
0.964 | - | - | - | 0.964 | - | - | Mlig455_010990 {REF} {Length: 546} {NoTransDecoderORF} | |
| 43. | MligTC455_13030 | 30 | 0.63 | Mlig455_030520 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_030520 {REF} {Length: 3950} {RNA1509_41925} {RNA1310_32300.1, RNA1509_41925} {RNA1509_41925, RNA815_29217} | |
| 44. | MligTC455_39312 | 101 | 2.11 | Mlig455_002158 | Neo: - Age: - |
CFAP99 | 0.964 | - | - | - | - | - | 0.964 | Mlig455_002158 {REF} {Length: 4740} {Pfam: Thyroglobulin type-1 repeat [PF00086.20, score=82.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=43.8]; Kazal-type serine protease inhibitor domain [PF07648.17, score=35.9]; Kazal-type serine protease inhibitor domain [PF00050.23, score=35.3]; EF-hand domain pair [PF13499.8, score=29.0]; EF-hand domain [PF13405.8, score=27.5]; EF hand [PF00036.34, score=23.2]; EF hand [PF13202.8, score=19.1]} {Human: ENSG00000206113, CFAP99, cilia and flagella associated protein 99, [RH, Score=302, Expect=4e-88]} {Mouse: ENSMUSG00000109572, Cfap99, cilia and flagella associated protein 99, [RH, Score=308, Expect=3e-90]} {Dmel: FBgn0262169, magu, [RH, Score=144, Expect=4e-35]} {Smed: dd_Smed_v6_8538_0_1, dd_Smed_v6_8538_0_1, [RH, Score=342, Expect=5e-103]} {RNA1509_16659} {RNA1310_6756} {RNA815_2531} |
| 45. | MligTC455_39707 | 209 | 4.34 | Mlig455_038773 | Neo: - Age: logFC(26M/2M)=-0.298 |
ANKRD17 | 0.964 | - | - | - | - | - | 0.964 | Mlig455_038773 {REF} {Length: 3788} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=96.6]; Ankyrin repeats (many copies) [PF13637.8, score=85.3]; Ankyrin repeats (many copies) [PF13857.8, score=60.3]; Ankyrin repeat [PF00023.32, score=53.1]; Ankyrin repeat [PF13606.8, score=47.0]} {Human: ENSG00000132466, ANKRD17, ankyrin repeat domain 17, [Score=59.7, Expect=2e-08]; ENSG00000145362, ANK2, ankyrin 2, [Score=57.0, Expect=1e-07]} {Mouse: ENSMUSG00000055204, Ankrd17, ankyrin repeat domain 17, [Score=55.8, Expect=2e-07]; ENSMUSG00000024483, Ankhd1, ankyrin repeat and KH domain containing 1, [Score=54.7, Expect=5e-07]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=63.2, Expect=8e-10]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=1e-05]} {Smed: dd_Smed_v6_10939_0_1, dd_Smed_v6_10939_0_1, [Score=57.0, Expect=2e-08]} {RNA1509_19518} {RNA1310_535.1} {RNA815_1832} |
| 46. | MligTC455_41296 | 43 | 0.9 | Mlig455_021118 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_021118 {REF} {Length: 2049} {RNA1509_59262} {RNA1310_31928} {RNA815_32415} | |
| 47. | MligTC455_25721 | 60 | 1.26 | Mlig455_004763 | Neo: - |
SLC43A3 | 0.963 | - | - | - | 0.963 | - | - | Mlig455_004763 {REF} {Length: 2625} {TRANSSPLICED} {Pfam: Sugar (and other) transporter [PF00083.26, score=18.6]} {Human: ENSG00000134802, SLC43A3, solute carrier family 43 member 3, [Score=71.6, Expect=1e-12]} {Smed: dd_Smed_v6_28076_0_1, dd_Smed_v6_28076_0_1, [Score=53.1, Expect=2e-07]} {RNA1509_12947} {RNA1310_7286.2} {RNA815_11365} |
| 48. | MligTC455_39894 | 42 | 0.88 | Mlig455_045042 | Neo: - Age: Down-Down-Up |
0.963 | - | - | - | - | 0.963 | - | Mlig455_045042 {REF} {Length: 1959} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=34.4]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=28.6]} {Smed: dd_Smed_v6_56224_0_1, dd_Smed_v6_56224_0_1, [Score=48.9, Expect=1e-06]} {RNA1310_63008} | |
| 49. | MligTC455_14087 | 22 | 0.46 | Mlig455_005059 | Neo: - Age: - |
SEC14L4 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_005059 {REF} {Length: 2564} {Pfam: CRAL/TRIO domain [PF00650.22, score=80.6]} {Human: ENSG00000133488, SEC14L4, SEC14 like lipid binding 4, [Score=145, Expect=5e-40]; ENSG00000100003, SEC14L2, SEC14 like lipid binding 2, [Score=140, Expect=7e-38]; ENSG00000214491, SEC14L6, SEC14 like lipid binding 6, [Score=139, Expect=3e-37]} {Mouse: ENSMUSG00000003585, Sec14l2, SEC14-like lipid binding 2, [Score=145, Expect=1e-39]; ENSMUSG00000054986, Sec14l3, SEC14-like lipid binding 3, [Score=142, Expect=2e-38]} {Dmel: FBgn0035146, CG13893, [Score=92.8, Expect=8e-21]} {Celegans: WBGene00011962, T23G5.2, CRAL-TRIO domain-containing protein T23G5.2, [Score=104, Expect=1e-24]} {Smed: dd_Smed_v6_12821_0_1, dd_Smed_v6_12821_0_1, [Score=155, Expect=8e-44]} {RNA1509_29843} {RNA1310_31007} {RNA815_24143} |
| 50. | MligTC455_22403 | 76 | 1.58 | Mlig455_043840, Mlig455_047410 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_043840 {REF} {Length: 1721} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_93309} {RNA815_54296} Mlig455_047410 {REF} {Length: 1771} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_96760.2} {RNA815_54296} |
|
| 51. | MligTC455_23024 | 42 | 0.88 | Mlig455_064155 | Neo: Int S/G2/M Age: - |
PRR9 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_064155 {REF} {Length: 2553} {Human: ENSG00000203783, PRR9, proline rich 9, [RH, Score=53.5, Expect=2e-08]} {Celegans: WBGene00018026, F35A5.4, [Score=80.9, Expect=1e-16]} {RNA1509_48555} {RNA1310_11521.2} {RNA815_6905.1} |
| 52. | MligTC455_23479 | 66 | 1.38 | Mlig455_010615 | Neo: - Age: Down-Down-Up |
0.962 | - | - | - | - | 0.962 | - | Mlig455_010615 {REF} {Length: 2310} {RNA1310_33311} {RNA815_31084} | |
| 53. | MligTC455_48960 | 52 | 1.09 | Mlig455_014079 | Neo: - Age: - |
0.962 | - | - | - | 0.962 | - | - | Mlig455_014079 {REF} {Length: 2345} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=25.9]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=21.0]} {Dmel: FBgn0034267, CG4984, [RH, Score=69.7, Expect=7e-13]} {Celegans: WBGene00016706, C46C11.3, [Score=47.4, Expect=4e-06]} {Smed: dd_Smed_v6_9946_0_1, dd_Smed_v6_9946_0_1, [RH, Score=56.2, Expect=5e-09]} {RNA1509_43217} {RNA1310_16701} {RNA815_8110} | |
| 54. | MligTC455_29874 | 65 | 1.36 | Mlig455_037947, Mlig455_068699 | Neo: - Age: logFC(26M/2M)=-0.467 |
ANKRD50 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_037947 {REF} {Length: 4099} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=309.9]; Ankyrin repeat [PF00023.32, score=295.0]; Ankyrin repeat [PF13606.8, score=230.6]; Ankyrin repeats (many copies) [PF13637.8, score=228.6]; Ankyrin repeats (many copies) [PF13857.8, score=200.7]; Glutamine amidotransferase domain [PF13537.8, score=68.9]; PEGA domain [PF08308.13, score=35.0]; Mab-21 protein [PF03281.16, score=29.5]; Nucleoplasmin/nucleophosmin domain [PF03066.17, score=26.4]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=276, Expect=2e-75]; ENSG00000029534, ANK1, ankyrin 1, [Score=270, Expect=5e-73]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=274, Expect=8e-75]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=256, Expect=7e-69]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=258, Expect=1e-69]} {Smed: dd_Smed_v6_2072_0_29, dd_Smed_v6_2072_0_29, [Score=256, Expect=2e-71]} {RNA1509_26004, RNA1509_28959} {RNA1310_3906.1, RNA1509_28959} {RNA1509_28959, RNA815_1664.1} Mlig455_068699 {REF} {Length: 2234} {Pfam: Mab-21 protein [PF03281.16, score=31.1]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} |
| 55. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 0.961 | - | - | - | - | 0.961 | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
| 56. | MligTC455_43486 | 59 | 1.22 | Mlig455_056889 | Neo: - Age: Up-Down-Down |
RCVRN | 0.961 | - | - | - | - | 0.961 | - | Mlig455_056889 {REF} {Length: 1808} {Pfam: EF-hand domain pair [PF13499.8, score=46.2]; EF hand [PF00036.34, score=42.1]; EF-hand domain [PF13405.8, score=40.1]; EF hand [PF13202.8, score=18.6]} {Human: ENSG00000109047, RCVRN, recoverin, [Score=51.6, Expect=4e-08]; ENSG00000138472, GUCA1C, guanylate cyclase activator 1C, [Score=50.4, Expect=1e-07]} {Mouse: ENSMUSG00000020907, Rcvrn, recoverin, [Score=48.9, Expect=2e-07]} {Smed: dd_Smed_v6_6534_0_2, dd_Smed_v6_6534_0_2, [Score=48.5, Expect=1e-07]} {RNA1509_37879} {RNA1310_35664, RNA1509_37879} {RNA1509_37879, RNA815_32400} |
| 57. | MligTC455_14352 | 18 | 0.38 | Mlig455_057678 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_057678 {REF} {Length: 2474} {NoTransDecoderORF} {RNA1509_25000} {RNA1310_23305} {RNA815_2326} | |
| 58. | MligTC455_40841 | 16 | 0.34 | Mlig455_003915, Mlig455_022710 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_003915 {REF} {Length: 3963} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=150.6]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=62.0, Expect=1e-09]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=64.3, Expect=1e-10]} {Smed: dd_Smed_v6_9790_0_1, dd_Smed_v6_9790_0_1, [Score=196, Expect=2e-55]} {RNA1509_1108} {RNA1310_105330} {RNA815_1603} Mlig455_022710 {REF} {Length: 2064} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=69.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=42.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.0]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=59.7, Expect=2e-09]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=71.2, Expect=4e-13]} {Celegans: WBGene00018728, frpr-8, FMRFamide Peptide Receptor family, [Score=54.7, Expect=6e-08]} {Smed: dd_Smed_v6_14651_0_1, dd_Smed_v6_14651_0_1, [RH, Score=161, Expect=9e-46]} {RNA1509_10628} {RNA1310_9160} {RNA815_10117.1} |
|
| 59. | MligTC455_46723 | 138 | 2.87 | Mlig455_066171 | Neo: - Age: - |
CHRNA6 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_066171 {REF} {Length: 1617} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=107.0]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=48.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=8e-32]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=123, Expect=2e-30]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=122, Expect=6e-30]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=131, Expect=2e-33]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=130, Expect=2e-33]} {Celegans: WBGene00006765, unc-29, Acetylcholine receptor subunit beta-type unc-29, [Score=92.0, Expect=4e-20]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [Score=142, Expect=2e-37]} {RNA1509_55012} {RNA1310_6313.1} {RNA815_3014.1} |
| 60. | MligTC455_15836 | 36 | 0.74 | Mlig455_000292 | Neo: - Age: Up-Down-Down |
PLEKHG5 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_000292 {REF} {Length: 4512} {Pfam: RhoGEF domain [PF00621.22, score=89.5]; PH domain [PF17838.3, score=20.5]; Pleckstrin homology domain [PF15405.8, score=19.2]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=197, Expect=6e-52]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=199, Expect=5e-53]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=6e-36]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=147, Expect=3e-36]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [RH, Score=179, Expect=8e-48]} {RNA1310_47096} {RNA815_53026} |
| 61. | MligTC455_50837 | 14 | 0.29 | Mlig455_013450 | Neo: - Age: - |
PLSCR5 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_013450 {REF} {Length: 1455} {Pfam: Scramblase [PF03803.17, score=121.2]} {Human: ENSG00000231213, PLSCR5, phospholipid scramblase family member 5, [Score=102, Expect=2e-24]; ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=97.8, Expect=3e-22]} {Mouse: ENSMUSG00000095654, Plscr5, phospholipid scramblase family, member 5, [Score=102, Expect=1e-24]; ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=97.8, Expect=2e-22]} {Dmel: FBgn0035390, scramb2, scramblase 2, [Score=87.8, Expect=2e-19]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=102, Expect=9e-25]} {Smed: dd_Smed_v6_4312_0_2, dd_Smed_v6_4312_0_2, [Score=92.4, Expect=1e-21]} {RNA1310_119369} |
| 62. | MligTC455_56085 | 3 | 0.06 | Mlig455_011162 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_011162 {REF} {Length: 371} {NoTransDecoderORF} | |
| 63. | MligTC455_15282 | 31 | 0.65 | Mlig455_003602, Mlig455_041578 | Neo: - Age: - |
ASIC3 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_003602 {REF} {Length: 2509} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=209.5]} {Human: ENSG00000213199, ASIC3, acid sensing ion channel subunit 3, [Score=68.6, Expect=3e-11]} {Mouse: ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=79.3, Expect=7e-15]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=83.2, Expect=2e-16]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=68.6, Expect=6e-12]} {RNA1509_55009} {RNA1310_54440} {RNA815_29220} Mlig455_041578 {REF} {Length: 3160} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=209.6]} {Human: ENSG00000213199, ASIC3, acid sensing ion channel subunit 3, [Score=68.6, Expect=3e-11]} {Mouse: ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=79.3, Expect=7e-15]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=83.2, Expect=2e-16]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=68.9, Expect=6e-12]} {RNA1509_55009} {RNA1310_54440} {RNA815_29220} |
| 64. | MligTC455_21638 | 50 | 1.05 | Mlig455_026393 | Neo: - Age: Down-Up-Down |
SLC6A5 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_026393 {REF} {Length: 1896} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=352.8]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=310, Expect=2e-97]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=309, Expect=3e-97]} {Dmel: FBgn0034911, CG5549, [Score=310, Expect=6e-95]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=226, Expect=2e-67]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=276, Expect=1e-85]} {RNA1509_16390} {RNA1310_7302.2} {RNA815_18232} |
| 65. | MligTC455_39313 | 100 | 2.07 | Mlig455_002259 | Neo: - Age: - |
SMOC1 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_002259 {REF} {Length: 2954} {Pfam: Thyroglobulin type-1 repeat [PF00086.20, score=83.6]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=49.9]; Kazal-type serine protease inhibitor domain [PF07648.17, score=37.6]; Kazal-type serine protease inhibitor domain [PF00050.23, score=36.6]; EF-hand domain [PF13405.8, score=31.1]; EF-hand domain pair [PF13499.8, score=30.2]; EF hand [PF00036.34, score=26.6]; EF hand [PF13202.8, score=20.9]} {Human: ENSG00000198732, SMOC1, SPARC related modular calcium binding 1, [RH, Score=80.5, Expect=3e-15]} {Mouse: ENSMUSG00000021136, Smoc1, SPARC related modular calcium binding 1, [RH, Score=82.4, Expect=4e-16]} {Dmel: FBgn0262169, magu, [RH, Score=145, Expect=4e-36]} {RNA1509_16659} {RNA1310_6756, RNA1509_16659} {RNA1509_16659, RNA815_13591} |
| 66. | MligTC455_08822 | 204 | 4.26 | Mlig455_021161, Mlig455_057860 | Neo: - Age: - |
GCH1 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_021161 {REF} {Length: 2321} {Pfam: GTP cyclohydrolase I [PF01227.24, score=244.1]} {Human: ENSG00000131979, GCH1, GTP cyclohydrolase 1, [RH, Score=295, Expect=7e-99]} {Mouse: ENSMUSG00000037580, Gch1, GTP cyclohydrolase 1, [RH, Score=293, Expect=2e-98]} {Dmel: FBgn0003162, Pu, Punch, [Score=276, Expect=2e-91]} {Celegans: WBGene00000298, cat-4, GTP cyclohydrolase 1, [Score=286, Expect=4e-96]} {Smed: dd_Smed_v6_11172_0_1, dd_Smed_v6_11172_0_1, [RH, Score=293, Expect=6e-99]} {RNA1509_45607} {RNA1310_1536.1} {RNA815_18903} Mlig455_057860 {REF} {Length: 1963} {Pfam: GTP cyclohydrolase I [PF01227.24, score=244.0]} {Human: ENSG00000131979, GCH1, GTP cyclohydrolase 1, [RH, Score=294, Expect=1e-98]} {Mouse: ENSMUSG00000037580, Gch1, GTP cyclohydrolase 1, [RH, Score=293, Expect=3e-98]} {Dmel: FBgn0003162, Pu, Punch, [Score=277, Expect=9e-92]} {Celegans: WBGene00000298, cat-4, GTP cyclohydrolase 1, [Score=286, Expect=4e-96]} {Smed: dd_Smed_v6_11172_0_1, dd_Smed_v6_11172_0_1, [RH, Score=294, Expect=3e-99]} {RNA1509_45607} {RNA1310_1536.1} {RNA815_18903} |
| 67. | MligTC455_38355 | 110 | 2.29 | Mlig455_039715, Mlig455_039769 | Neo: - Age: - |
KCNB2 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_039715 {REF} {Length: 3883} {Pfam: Ion transport protein [PF00520.33, score=114.4]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=218, Expect=3e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=213, Expect=2e-60]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=213, Expect=7e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=210, Expect=2e-59]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=7e-59]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=219, Expect=5e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=8e-61]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=213, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=8e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=236, Expect=3e-69]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} Mlig455_039769 {REF} {Length: 4176} {Pfam: Ion transport protein [PF00520.33, score=116.7]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]; Polycystin cation channel [PF08016.14, score=20.7]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=219, Expect=8e-61]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=216, Expect=2e-61]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=215, Expect=2e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=213, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=213, Expect=4e-60]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=210, Expect=4e-58]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=221, Expect=2e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=219, Expect=4e-61]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=216, Expect=6e-62]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=215, Expect=6e-61]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=211, Expect=1e-58]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=231, Expect=2e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=239, Expect=2e-70]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=595, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} |
| 68. | MligTC455_39012 | 61 | 1.27 | Mlig455_030044 | Neo: - Age: Up-Down-Up |
PLCB3 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_030044 {REF} {Length: 5860} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=196.5]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=125.0]; PH domain [PF17787.3, score=121.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=32.2]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=824, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=823, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=823, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=811, Expect=0.0]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=666, Expect=0.0]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=681, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=724, Expect=0.0]} {RNA1509_47106} {RNA1310_7555} {RNA815_2033} |
| 69. | MligTC455_41106 | 42 | 0.88 | Mlig455_010275 | Neo: - Age: - Region-enriched R2: 5.386/0.03242 |
CALM1 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265} |
| 70. | MligTC455_43454 | 36 | 0.74 | Mlig455_043999 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_043999 {REF} {Length: 2456} {Dmel: FBgn0259222, CG42322, [RH, Score=101, Expect=3e-22]} {Smed: dd_Smed_v6_18554_0_1, dd_Smed_v6_18554_0_1, [Score=82.4, Expect=1e-17]} {RNA1310_20749} {RNA815_38231} | |
| 71. | MligTC455_20767 | 205 | 4.27 | Mlig455_000225 | Neo: - Age: Up-Down-Down |
CALCR | 0.956 | - | - | - | - | 0.956 | - | Mlig455_000225 {REF} {Length: 2351} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=148.2]; Hormone receptor domain [PF02793.24, score=36.9]} {Human: ENSG00000004948, CALCR, calcitonin receptor, [Score=133, Expect=7e-33]} {Mouse: ENSMUSG00000023964, Calcr, calcitonin receptor, [Score=144, Expect=2e-36]} {Dmel: FBgn0260753, Pdfr, Pigment-dispersing factor receptor, [Score=214, Expect=1e-60]} {Celegans: WBGene00015735, pdfr-1, Calcitonin receptor-like protein 1, [Score=178, Expect=2e-48]} {Smed: dd_Smed_v6_22246_0_1, dd_Smed_v6_22246_0_1, [RH, Score=198, Expect=5e-57]} {RNA1310_16931.2} {RNA815_17279} |
| 72. | MligTC455_41993 | 177 | 3.68 | Mlig455_058555 | Neo: - Age: - |
SLC18A2 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_058555 {REF} {Length: 2488} {Pfam: Major Facilitator Superfamily [PF07690.18, score=160.2]} {Human: ENSG00000165646, SLC18A2, solute carrier family 18 member A2, [RH, Score=505, Expect=4e-173]} {Mouse: ENSMUSG00000025094, Slc18a2, solute carrier family 18 (vesicular monoamine), member 2, [RH, Score=506, Expect=9e-174]} {Dmel: FBgn0260964, Vmat, Vesicular monoamine transporter, [RH, Score=522, Expect=9e-179]} {Celegans: WBGene00000295, cat-1, [RH, Score=478, Expect=1e-162]} {Smed: dd_Smed_v6_16043_0_1, dd_Smed_v6_16043_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_54526} {RNA1310_13917.1} {RNA815_24305} |
| 73. | MligTC455_14039 | 24 | 0.5 | Mlig455_045412 | Neo: - Age: - |
ANGPTL3 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_045412 {REF} {Length: 1491} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=55.0]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=48.9, Expect=1e-05]} {Dmel: FBgn0031804, CG9500, [Score=63.9, Expect=3e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=58.2, Expect=4e-09]} {RNA1509_53291} {RNA1310_91324} {RNA815_10579.1} |
| 74. | MligTC455_40199 | 64 | 1.33 | Mlig455_026444, Mlig455_026477 | Neo: - Age: - |
ASIC4 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_026444 {REF} {Length: 2570} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.4, Expect=7e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]; ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.7, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=119, Expect=6e-28]} {RNA1310_21223} {RNA815_27174} Mlig455_026477 {REF} {Length: 2402} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=160.5]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.0, Expect=8e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.3, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=93.6, Expect=9e-20]} {RNA1310_21223} {RNA815_27174} |
| 75. | MligTC455_45881 | 285 | 5.94 | Mlig455_051535 | Neo: Irradiation Age: Up-Down-Down Region-enriched R2: 4.287/0.00883 |
CALM2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_051535 {REF} {Length: 1911} {Pfam: EF-hand domain pair [PF13499.8, score=44.7]; EF-hand domain [PF14658.8, score=28.5]; EF-hand domain [PF13405.8, score=18.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=83.2, Expect=5e-18]; ENSG00000198668, CALM1, calmodulin 1, [Score=83.2, Expect=1e-18]; ENSG00000160014, CALM3, calmodulin 3, [Score=82.8, Expect=2e-18]} {Mouse: ENSMUSG00000036438, Calm2, calmodulin 2, [Score=82.8, Expect=1e-18]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=82.8, Expect=1e-18]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=82.8, Expect=1e-18]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.4, Expect=1e-18]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=82.4, Expect=1e-18]} {RNA1509_41430} {RNA1310_57772} {RNA815_28870} |
| 76. | MligTC455_51271 | 681 | 14.19 | Mlig455_021899, Mlig455_021976, Mlig455_022029 | Neo: - Age: - Region-specific R2: 6.767 Region-enriched R2: 4.145/0.01904 |
FOXA2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_021899 {REF} {Length: 3015} {Pfam: Forkhead domain [PF00250.20, score=129.1]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=224, Expect=1e-66]; ENSG00000129514, FOXA1, forkhead box A1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=228, Expect=3e-68]} {Dmel: FBgn0000659, fkh, fork head, [Score=233, Expect=8e-70]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=197, Expect=9e-58]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=239, Expect=1e-72]} {RNA1509_29593, RNA1509_56864} {RNA1310_6263, RNA1509_29593, RNA1509_56864} {RNA1509_29593, RNA1509_56864, RNA815_8556} Mlig455_021976 {REF} {Length: 2892} {Pfam: Forkhead domain [PF00250.20, score=129.2]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=222, Expect=2e-66]; ENSG00000129514, FOXA1, forkhead box A1, [Score=214, Expect=3e-63]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=226, Expect=4e-68]} {Dmel: FBgn0000659, fkh, fork head, [Score=231, Expect=1e-69]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=196, Expect=4e-57]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=238, Expect=1e-72]} {RNA1509_29593} {RNA1310_6263} {RNA815_8556} Mlig455_022029 {REF} {Length: 3066} {Pfam: Forkhead domain [PF00250.20, score=31.9]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=80.9, Expect=5e-17]; ENSG00000129514, FOXA1, forkhead box A1, [Score=80.1, Expect=7e-17]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=83.6, Expect=4e-18]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=80.1, Expect=3e-17]; ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=79.7, Expect=6e-17]} {Dmel: FBgn0000659, fkh, fork head, [Score=89.0, Expect=3e-20]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=72.8, Expect=9e-15]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=103, Expect=1e-25]} {RNA1509_29593} {RNA1310_6263} {RNA815_8556} |
| 77. | MligTC455_00722 | 98 | 2.04 | Mlig455_029527 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_029527 {REF} {Length: 63} {NoTransDecoderORF} | |
| 78. | MligTC455_15694 | 54 | 1.13 | Mlig455_026426, Mlig455_026456 | Neo: - Age: - Region-enriched R2: 6.151/0.00957 |
SSTR1 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_026426 {REF} {Length: 2191} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.7]; Olfactory receptor [PF13853.8, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=6e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=4e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=5e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=2e-33]} {RNA1310_38996} {RNA815_25059} Mlig455_026456 {REF} {Length: 2423} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=26.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=5e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=3e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=7e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=110, Expect=2e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=1e-33]} {RNA1310_38996} {RNA815_25059} |
| 79. | MligTC455_30454 | 39 | 0.82 | Mlig455_022994 | Neo: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_022994 {REF} {Length: 1336} {Pfam: Phage integrase family [PF00589.24, score=23.1]} {RNA1509_25737} {RNA1310_2048} {RNA815_551.1} | |
| 80. | MligTC455_32573 | 34 | 0.71 | Mlig455_050903, Mlig455_067814 | Neo: - Age: Up-Down-Up |
CHRNA2 | 0.954 | - | - | - | - | - | 0.954 | Mlig455_050903 {REF} {Length: 2028} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=98.7]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=208, Expect=2e-59]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=206, Expect=2e-59]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=204, Expect=3e-57]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=198, Expect=6e-56]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=203, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=201, Expect=4e-56]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=199, Expect=3e-56]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=198, Expect=3e-56]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=197, Expect=7e-56]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=1e-57]} {Celegans: WBGene00002974, lev-1, Acetylcholine receptor subunit beta-type lev-1, [Score=194, Expect=1e-54]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=426, Expect=7e-143]} {RNA1509_37874} {RNA1310_43734} {RNA815_13595} Mlig455_067814 {REF} {Length: 2696} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=158.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=99.0]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=208, Expect=4e-60]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=207, Expect=3e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=203, Expect=3e-57]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=198, Expect=2e-56]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=203, Expect=9e-59]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=200, Expect=3e-56]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=199, Expect=6e-57]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=197, Expect=3e-56]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=197, Expect=2e-56]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00002974, lev-1, Acetylcholine receptor subunit beta-type lev-1, [Score=194, Expect=3e-55]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=426, Expect=1e-143]} {RNA1509_37874} {RNA1310_43734} {RNA815_13595} |
| 81. | MligTC455_42530 | 41 | 0.86 | Mlig455_064531 | Neo: - Age: - |
RASL12 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_064531 {REF} {Length: 4677} {Pfam: Ras family [PF00071.24, score=65.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=24.9]} {Human: ENSG00000103710, RASL12, RAS like family 12, [Score=88.6, Expect=3e-20]; ENSG00000134533, RERG, RAS like estrogen regulated growth inhibitor, [Score=87.4, Expect=3e-20]} {Mouse: ENSMUSG00000092164, Rergl, RERG/RAS-like, [Score=89.4, Expect=3e-21]; ENSMUSG00000030222, Rerg, RAS-like, estrogen-regulated, growth-inhibitor, [Score=87.4, Expect=2e-20]} {Dmel: FBgn0035711, CG8519, [Score=88.6, Expect=6e-21]} {Celegans: WBGene00021811, ral-1, RAL (Ras-related GTPase) homolog, [Score=65.5, Expect=2e-12]} {Smed: dd_Smed_v6_7273_0_1, dd_Smed_v6_7273_0_1, [Score=87.8, Expect=6e-21]} {RNA1310_147102} |
| 82. | MligTC455_51176 | 71 | 1.48 | Mlig455_024765 | Neo: - Age: - |
SAXO1 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_024765 {REF} {Length: 1803} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.5, Expect=9e-06]} {Smed: dd_Smed_v6_5551_0_1, dd_Smed_v6_5551_0_1, [Score=55.5, Expect=2e-08]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
| 83. | MligTC455_37082 | 72 | 1.5 | Mlig455_019298, Mlig455_019518 | Neo: - Age: - |
RCBTB1 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_019298 {REF} {Length: 4230} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=197.1]; Ankyrin repeats (many copies) [PF13637.8, score=150.2]; Regulator of chromosome condensation (RCC1) repeat [PF00415.20, score=148.3]; Ankyrin repeat [PF00023.32, score=140.7]; Ankyrin repeat [PF13606.8, score=126.3]; Ankyrin repeats (many copies) [PF13857.8, score=108.3]; Regulator of chromosome condensation (RCC1) repeat [PF13540.8, score=71.0]; BTB/POZ domain [PF00651.33, score=66.0]} {Human: ENSG00000136144, RCBTB1, RCC1 and BTB domain containing protein 1, [RH, Score=447, Expect=9e-146]; ENSG00000136161, RCBTB2, RCC1 and BTB domain containing protein 2, [RH, Score=428, Expect=2e-138]} {Mouse: ENSMUSG00000035469, Rcbtb1, regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1, [RH, Score=453, Expect=2e-148]; ENSMUSG00000022106, Rcbtb2, regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2, [RH, Score=436, Expect=3e-141]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=189, Expect=3e-48]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=178, Expect=5e-45]} {Smed: dd_Smed_v6_6898_0_1, dd_Smed_v6_6898_0_1, [Score=166, Expect=3e-42]} {RNA1509_46037} {RNA1310_5158.1} {RNA815_6143} Mlig455_019518 {REF} {Length: 4053} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=198.9]; Ankyrin repeats (many copies) [PF13637.8, score=153.0]; Regulator of chromosome condensation (RCC1) repeat [PF00415.20, score=148.4]; Ankyrin repeat [PF00023.32, score=140.6]; Ankyrin repeat [PF13606.8, score=126.9]; Ankyrin repeats (many copies) [PF13857.8, score=108.4]; Regulator of chromosome condensation (RCC1) repeat [PF13540.8, score=71.4]; BTB/POZ domain [PF00651.33, score=66.0]} {Human: ENSG00000136144, RCBTB1, RCC1 and BTB domain containing protein 1, [RH, Score=445, Expect=4e-145]; ENSG00000136161, RCBTB2, RCC1 and BTB domain containing protein 2, [RH, Score=428, Expect=2e-138]} {Mouse: ENSMUSG00000035469, Rcbtb1, regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1, [RH, Score=451, Expect=1e-147]; ENSMUSG00000022106, Rcbtb2, regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2, [RH, Score=435, Expect=2e-141]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=187, Expect=1e-47]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=178, Expect=5e-45]} {Smed: dd_Smed_v6_6898_0_1, dd_Smed_v6_6898_0_1, [Score=166, Expect=3e-42]} {RNA1509_46037} {RNA1310_5158.1} {RNA815_6143} |
| 84. | MligTC455_50328 | 128 | 2.66 | Mlig455_039843 | Neo: - Age: - |
SCNN1B | 0.953 | - | - | - | - | 0.953 | - | Mlig455_039843 {REF} {Length: 2793} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=206.6]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=69.3, Expect=1e-11]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=58.9, Expect=1e-08]; ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=75.5, Expect=8e-14]} {Smed: dd_Smed_v6_23028_0_1, dd_Smed_v6_23028_0_1, [RH, Score=366, Expect=3e-118]} {RNA1509_37054} {RNA1310_10450, RNA1509_37054} {RNA1509_37054, RNA815_17111} |
| 85. | MligTC455_10754 | 10 | 0.2 | Mlig455_035686 | Neo: - Age: - |
OTX2 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_035686 {REF} {Length: 2705} {Pfam: Homeodomain [PF00046.31, score=73.1]} {Human: ENSG00000165588, OTX2, orthodenticle homeobox 2, [RH, Score=127, Expect=5e-33]} {Mouse: ENSMUSG00000021848, Otx2, orthodenticle homeobox 2, [RH, Score=127, Expect=6e-34]} {Dmel: FBgn0004102, oc, ocelliless, [RH, Score=124, Expect=2e-30]} {Celegans: WBGene00006652, ttx-1, Homeodomain protein TTX-1, [Score=120, Expect=3e-30]} {Smed: dd_Smed_v6_14633_0_1, dd_Smed_v6_14633_0_1, [RH, Score=102, Expect=3e-23]} {RNA1509_34770} {RNA1310_31442} {RNA815_3742.2} |
| 86. | MligTC455_10755 | 10 | 0.2 | Mlig455_035782 | Neo: - Age: - |
OTX2 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_035782 {REF} {Length: 1715} {Pfam: Homeodomain [PF00046.31, score=73.1]} {Human: ENSG00000165588, OTX2, orthodenticle homeobox 2, [RH, Score=127, Expect=5e-33]} {Mouse: ENSMUSG00000021848, Otx2, orthodenticle homeobox 2, [RH, Score=127, Expect=6e-34]} {Dmel: FBgn0004102, oc, ocelliless, [RH, Score=124, Expect=2e-30]} {Celegans: WBGene00006652, ttx-1, Homeodomain protein TTX-1, [Score=120, Expect=3e-30]} {Smed: dd_Smed_v6_14633_0_1, dd_Smed_v6_14633_0_1, [RH, Score=102, Expect=3e-23]} {RNA1509_34770} {RNA1310_31442} {RNA815_3742.2} |
| 87. | MligTC455_18227 | 82 | 1.71 | Mlig455_014781 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_014781 {REF} {Length: 4541} {Pfam: Ankyrin repeats (many copies) [PF13857.8, score=26.2]; Mab-21 protein [PF03281.16, score=25.9]} {RNA1509_35479} {RNA1310_2311.1} {RNA815_13099} | |
| 88. | MligTC455_22923 | 53 | 1.1 | Mlig455_068434 | Neo: - Age: Down-Up-Down |
MYLK3 | 0.951 | - | - | - | - | - | 0.951 | Mlig455_068434 {REF} {Length: 2249} {Pfam: Protein kinase domain [PF00069.27, score=28.7]} {Human: ENSG00000140795, MYLK3, myosin light chain kinase 3, [Score=49.7, Expect=1e-07]} {Mouse: ENSMUSG00000031698, Mylk3, myosin light chain kinase 3, [Score=49.7, Expect=9e-08]} {Dmel: FBgn0265045, Strn-Mlck, Stretchin-Mlck, [Score=48.5, Expect=1e-07]} {Smed: dd_Smed_v6_8041_0_1, dd_Smed_v6_8041_0_1, [Score=49.3, Expect=4e-08]} {RNA1509_36787} {RNA1310_62109} {RNA815_9443} |
| 89. | MligTC455_37026 | 109 | 2.28 | Mlig455_029463 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_029463 {REF} {Length: 788} {RNA1310_43520} {RNA815_2407} | |
| 90. | MligTC455_15212 | 12 | 0.26 | Mlig455_059838 | Neo: - Age: - |
ADRA2A | 0.95 | - | - | - | - | 0.950 | - | Mlig455_059838 {REF} {Length: 2182} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=239.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=36.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.6]; Olfactory receptor [PF13853.8, score=28.5]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=200, Expect=2e-57]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=198, Expect=1e-56]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=185, Expect=5e-51]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=195, Expect=5e-56]} {Smed: dd_Smed_v6_19063_0_1, dd_Smed_v6_19063_0_1, [Score=235, Expect=1e-71]} |
| 91. | MligTC455_18091 | 71 | 1.49 | Mlig455_014664 | Neo: - Age: - |
ARL3 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_014664 {REF} {Length: 1771} {Pfam: ADP-ribosylation factor family [PF00025.23, score=67.3]; 50S ribosome-binding GTPase [PF01926.25, score=26.6]; G-protein alpha subunit [PF00503.22, score=19.1]} {Human: ENSG00000138175, ARL3, ADP ribosylation factor like GTPase 3, [Score=67.8, Expect=2e-13]; ENSG00000122644, ARL4A, ADP ribosylation factor like GTPase 4A, [Score=67.8, Expect=3e-13]; ENSG00000143761, ARF1, ADP ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSG00000168374, ARF4, ADP ribosylation factor 4, [Score=65.1, Expect=2e-12]; ENSG00000134287, ARF3, ADP ribosylation factor 3, [Score=65.1, Expect=2e-12]; ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=64.7, Expect=4e-12]} {Mouse: ENSMUSG00000047446, Arl4a, ADP-ribosylation factor-like 4A, [Score=67.4, Expect=2e-13]; ENSMUSG00000025035, Arl3, ADP-ribosylation factor-like 3, [Score=66.6, Expect=4e-13]; ENSMUSG00000048076, Arf1, ADP-ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSMUSG00000051853, Arf3, ADP-ribosylation factor 3, [Score=65.1, Expect=1e-12]; ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=64.3, Expect=3e-12]} {Dmel: FBgn0013749, Arf102F, ADP ribosylation factor at 102F, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00000184, arf-6, ADP-Ribosylation Factor related, [Score=65.5, Expect=5e-13]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=78.6, Expect=7e-18]} {RNA1310_41790} {RNA815_35492} |
| 92. | MligTC455_33356 | 149 | 3.11 | Mlig455_025778 | Neo: - Age: - |
SP4 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_025778 {REF} {Length: 2800} {Pfam: Zinc-finger double domain [PF13465.8, score=45.8]; Zinc finger, C2H2 type [PF00096.28, score=44.8]; C2H2-type zinc finger [PF13894.8, score=29.7]} {Human: ENSG00000105866, SP4, Sp4 transcription factor, [RH, Score=186, Expect=2e-52]; ENSG00000185591, SP1, Sp1 transcription factor, [RH, Score=180, Expect=5e-50]} {Mouse: ENSMUSG00000025323, Sp4, trans-acting transcription factor 4, [RH, Score=190, Expect=6e-54]} {Dmel: FBgn0039169, Spps, Sp1-like factor for pairing sensitive-silencing, [RH, Score=174, Expect=4e-48]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [RH, Score=155, Expect=1e-43]} {Smed: dd_Smed_v6_7824_0_1, dd_Smed_v6_7824_0_1, [RH, Score=171, Expect=1e-49]} {RNA1509_53494} {RNA1310_27619} {RNA815_23917} |
| 93. | MligTC455_50491 | 751 | 15.65 | Mlig455_012096 | Neo: - Age: - Region-enriched R2: 1.944/0.00216 |
FAP | 0.95 | - | - | - | - | 0.950 | - | Mlig455_012096 {REF} {Length: 1121} {Pfam: Prolyl oligopeptidase family [PF00326.23, score=66.9]} {Human: ENSG00000078098, FAP, fibroblast activation protein alpha, [Score=87.4, Expect=4e-20]} {Mouse: ENSMUSG00000000392, Fap, fibroblast activation protein, [Score=84.7, Expect=2e-19]} {Dmel: FBgn0031741, CG11034, [Score=87.0, Expect=3e-20]} {Celegans: WBGene00001055, dpf-2, Dipeptidyl peptidase family member 2, [Score=77.0, Expect=6e-17]} {Smed: dd_Smed_v6_9183_0_1, dd_Smed_v6_9183_0_1, [Score=102, Expect=7e-26]} {RNA1509_12435} {RNA1310_3631.1} {RNA815_1805} |